David Marshall is the chief investment officer at Venturewave and a key investment committee member. With over 20 years of experience, David specialises in corporate development, strategic financial planning, investor relations, and ESG integration across public and private sectors. His expertise includes successfully leading complex financial transactions, significant debt refinancings, corporate acquisitions, and divestitures, consistently delivering substantial stakeholder value.

Before joining Venturewave in 2024, David held senior roles in notable international businesses including Digicel Group, UDG Healthcare, and Elan Corporation. He managed and executed financial transactions exceeding $5 billion, notably leading a €330 million public company sale at over 50% premium for shareholders. David executed a major $3 billion debt restructuring at Digicel in a broader $5 billion refinancing programme.

Previously, David contributed strategically at Investec (formerly NCB Group) in institutional equity sales and as a top-ranked senior equity analyst in European healthcare. His analytical insights directly supported successful M&A activities and significant fundraisings for healthcare and technology firms.

As CIO, David leads Venturewave’s portfolio management, deal sourcing, and strategic investment initiatives, incorporating his extensive experience in capital markets and impact investing. He also serves as a board director on several portfolio companies, where he actively implements strategic frameworks for sustainable growth and investor engagement.

David holds a Ph.D. in Molecular Biology and a B.A. (Mod) in Natural Sciences from Trinity College Dublin. His educational background, complemented by executive training in negotiation and corporate strategy from INSEAD, Paris, uniquely positions him to align scientific rigour with financial acumen, driving Venturewave’s mission of delivering impactful and economically successful outcomes globally.

Learn more about the Venturewave leadership team that shapes innovation and impact globally.